New Drugs for Myelodysplastic Syndromes on the Horizon

A recent market report indicates that five new drugs for treatment of the blood-related conditions will likely hit the market by 2018.

http://www.pmpnews.com/article/new-drugs-myelodysplastic-syndromes-horizon